These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 9713479)
1. A case with small cell carcinoma of the esophagus: measurement of tumor markers, including pro-gastrin-releasing peptide. Yanagawa H; Shimada K; Tanaka H; Takeuchi E; Maniwa K; Suzuki Y; Ogushi F; Sano N; Izumi K; Sone S Anticancer Res; 1998; 18(4B):2877-80. PubMed ID: 9713479 [TBL] [Abstract][Full Text] [Related]
2. Primary small cell carcinoma of the esophagus with achalasia in a patient in whom pro-gastrin-releasing peptide and neuron-specific enolase levels reflected the clinical course during chemotherapy. Suzuki H; Takayanagi S; Otake T; Ishibashi R; Osawa S; Shirai T; Takashima M; Hanai H; Kaneko E J Gastroenterol; 1999 Jun; 34(3):378-82. PubMed ID: 10433016 [TBL] [Abstract][Full Text] [Related]
3. Small cell carcinoma of the esophagus with reference to alternating multiagent chemotherapy: report of two cases. Koide N; Hiraguri M; Kishimoto K; Nakamura T; Adachi W; Miyabayashi H; Terai N; Amano J Surg Today; 2003; 33(4):294-8. PubMed ID: 12707827 [TBL] [Abstract][Full Text] [Related]
4. KIT and PDGFRA in esophageal pure small cell carcinoma. Terada T Int J Clin Exp Pathol; 2011; 4(7):718-21. PubMed ID: 22076173 [TBL] [Abstract][Full Text] [Related]
5. Small cell carcinoma of the esophagus combined with superficial esophageal cancer. Fujiwara Y; Nakagawa K; Tanaka T; Utsunomiya J; Nishigami T; Uematsu K Hepatogastroenterology; 1996; 43(11):1360-9. PubMed ID: 8908575 [TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy for a senile patient with adenoid cystic carcinoma of the esophagus: a case report. Matsumoto M; Nomiyama T; Nakae J; Nishikawa H Jpn J Clin Oncol; 1993 Aug; 23(4):258-62. PubMed ID: 8411740 [TBL] [Abstract][Full Text] [Related]
7. Oat-cell carcinoma of the esophagus. Valls C; Sanchez-Laforga A; Benasco C AJR Am J Roentgenol; 1994 Nov; 163(5):1266-7. PubMed ID: 7976920 [No Abstract] [Full Text] [Related]
9. Increased serum concentrations of pro-gastrin-releasing peptide in patients with renal dysfunction. Kamata K; Uchida M; Takeuchi Y; Takahashi E; Sato N; Miyake Y; Okubo M; Kodama T; Yamaguchi K Nephrol Dial Transplant; 1996 Jul; 11(7):1267-70. PubMed ID: 8672021 [TBL] [Abstract][Full Text] [Related]
10. [Stage IV small cell esophageal carcinoma that responded to various chemotherapeutic regimens with relative longevity - a case report]. Yamakoshi Y; Kubo N; Ohira M; Sakurai K; Toyokawa T; Shibutani M; Yamazoe S; Nagahara H; Kimura K; Amano R; Tanaka H; Muguruma K; Ohtani H; Yashiro M; Maeda K; Hirakawa K Gan To Kagaku Ryoho; 2014 Nov; 41(12):2021-3. PubMed ID: 25731409 [TBL] [Abstract][Full Text] [Related]
11. Gastrin-releasing peptide-, calcitonin gene-related peptide-, and calcitonin-like immunoreactivity in human breast cyst fluid and gastrin-releasing peptide-like immunoreactivity in human breast carcinoma cell lines. Weber CJ; O'Dorisio TM; McDonald TJ; Howe B; Koschitzky T; Merriam L Surgery; 1989 Dec; 106(6):1134-9; discussion 1139-40. PubMed ID: 2588117 [TBL] [Abstract][Full Text] [Related]
12. Elevated serum progastrin-releasing peptide (31-98) level is a predictor of short response duration after hormonal therapy in metastatic prostate cancer. Yashi M; Nukui A; Kurokawa S; Ochi M; Ishikawa S; Goto K; Kobayashi Y; Muraishi O; Tokue A Prostate; 2003 Sep; 56(4):305-12. PubMed ID: 12858359 [TBL] [Abstract][Full Text] [Related]
13. [A patient with small-cell carcinoma of the esophagus with synchronous liver metastasis surviving 48 months after surgery]. Nagahama T; Maruyama M; Tokairin Y; Yoshida T; Baba H; Kure N; Ebuchi M Gan To Kagaku Ryoho; 2001 Oct; 28(11):1655-8. PubMed ID: 11708001 [TBL] [Abstract][Full Text] [Related]
14. [A case report of primary small cell esophageal carcinoma responding successfully to radiochemotherapy]. Matsumori T; Murakami S; Araki O; Tsuda T; Sasaki A; Goto N; Adachi K; Shimada Y; Hayashi M; Itani T; Mimura J; Hashimoto K Gan To Kagaku Ryoho; 2012 Jul; 39(7):1119-21. PubMed ID: 22790051 [TBL] [Abstract][Full Text] [Related]
15. Primary oat cell carcinoma of the esophagus. Ignacio AG; Chintapalli K; Choi HY Am J Gastroenterol; 1987 Jan; 82(1):78-81. PubMed ID: 3026169 [TBL] [Abstract][Full Text] [Related]
16. Primary metastatic neuroendocrine small cell bladder cancer: a case report and literature review. Cerulli C; Busetto GM; Antonini G; Giovannone R; Di Placido M; Soda G; De Berardinis E; Gentile V Urol Int; 2012; 88(3):365-9. PubMed ID: 22236613 [TBL] [Abstract][Full Text] [Related]
17. Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma. Miyake Y; Kodama T; Yamaguchi K Cancer Res; 1994 Apr; 54(8):2136-40. PubMed ID: 8174119 [TBL] [Abstract][Full Text] [Related]
18. [Small cell anaplastic carcinoma of the esophagus]. Casas Fernández-Tejerina J; Jiménez C; Hernández R; Guarch R; de Miguel C; Rivero A Rev Clin Esp; 1989 Mar; 184(4):220-1. PubMed ID: 2544934 [No Abstract] [Full Text] [Related]
19. Superficial primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical analysis of 15 cases. Lu J; Xue LY; Lu N; Zou SM; Liu XY; Wen P Dis Esophagus; 2010 Feb; 23(2):153-9. PubMed ID: 19515193 [TBL] [Abstract][Full Text] [Related]
20. [A patient with stage IVb small cell carcinoma of the esophagus who survived 23 months after systemic cancer chemotherapy]. Tsujie M; Shibata N; Nomura T; Tanaka T; Morimoto T; Fujita S; Kitani K; Nakahira S; Okuda H; Takeda M Gan To Kagaku Ryoho; 2003 Feb; 30(2):271-5. PubMed ID: 12610878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]